8-K: Baker Hughes Announces Board Changes: Elsenhans to Depart, Kadri Appointed

Lynn L. Elsenhans will not stand for re-election, and Ilham Kadri has been elected to the Board of Directors, effective May 1, 2025.

Summary

• Baker Hughes Company announced that Lynn L. Elsenhans will not seek re-election at the upcoming 2025 Annual Meeting of Shareholders.
• Ms. Elsenhans has served on the Board since 2019 and with predecessor entities since 2012.
• Ilham Kadri has been elected to the Board, with her term beginning on May 1, 2025.
• The Board size will increase from ten to eleven members.
• Dr. Kadri is the current CEO of Syensqo S.A. and previously served as CEO of Solvay S.A.
• She has extensive leadership experience across various industries and has served as a director for A.O. Smith Corporation and LOral S.A.
• The Board has determined that Dr. Kadri is independent and qualifies as an audit committee financial expert.
• Dr. Kadri will serve on the Audit and Human Capital and Compensation Committees.
• Her compensation will align with other non-employee directors.
• Dr. Kadri will enter into a standard indemnification agreement with the Company.

Sentiment

Score: 7

Explanation: The announcement is neutral to positive, reflecting a standard board transition with the addition of an experienced director. The tone is professional and appreciative of the outgoing director's contributions.

Positives

• The addition of Ilham Kadri brings extensive leadership experience from various industries and leading industrial multinationals.
• Dr. Kadri's qualifications as an audit committee financial expert strengthens the Board's expertise.
• The Board has determined that Dr. Kadri is independent under the corporate governance requirements of Nasdaq, the Company's Corporate Governance Principles, Rule 10A-3 of the Securities Exchange Act of 1934, as amended (the Exchange Act) and Rule 10C-1 of the Exchange Act.

Management Comments

• The Board sincerely thanks Ms. Elsenhans for her significant contributions to the Company and wishes her every success in her future endeavors.

Industry Context

Board changes are a common occurrence in publicly traded companies, reflecting the evolving needs and strategic direction of the organization. The appointment of a new director with experience in a different sector could bring fresh perspectives and insights to Baker Hughes.

Comparison to Industry Standards

• Baker Hughes' board composition and governance practices are generally in line with industry standards for large, publicly traded companies.
• The company's adherence to Nasdaq's corporate governance requirements and the determination of Dr. Kadri's independence reflect a commitment to best practices.
• Comparable companies like Schlumberger and Halliburton also maintain boards with diverse expertise and independent directors.

Management Changes

Stakeholder Impact

• Shareholders may view the board changes as an opportunity for fresh perspectives and continued strong governance.
• Employees may be indirectly affected by any strategic shifts resulting from the new board member's influence.

Next Steps

• Ilham Kadri will join the Board and serve on the Audit and Human Capital and Compensation Committees effective May 1, 2025.
• Lynn L. Elsenhans will depart from the Board after the 2025 Annual Meeting of Shareholders.

Key Dates

Keywords

Board of Directors, Ilham Kadri, Lynn L. Elsenhans, Corporate Governance, Baker Hughes